Nobuyoshi Shimizu
- Physiology top 0.05%
- Neurology top 0.1%
- Cellular and Molecular Neuroscience top 0.2%
- Genetics top 0.1%
- Molecular Biology top 0.2%
- RNA modifications and cancer 29
- Glycosylation and Glycoproteins Research 28
-
- Organ Transplantation Techniques and Outcomes 41
- Transplantation: Methods and Outcomes 38
-
- Monoclonal and Polyclonal Antibodies Research 28
-
- HER2/EGFR in Cancer Research 27
-
- Lung Cancer Treatments and Mutations 26
-
- Chromosomal and Genetic Variations 25
- Co-authors
- Shuichi AsakawaSatoshi MinoshimaYoshikuni MizunoNobutaka HattoriTohru KitadaHiroto MatsumineYasuhiro YamamuraJun Kudoh
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Nobuyoshi Shimizu
525 papers receiving 27.0k citations
Hit Papers
Peers
Comparison fields: 5 of 163
- Physiology 1.6k
- Neurology 4.7k
- Cellular and Molecular Neuroscience 3.5k
- Genetics 5.2k
- Molecular Biology 12.5k
Countries citing papers authored by Nobuyoshi Shimizu
This map shows the geographic impact of Nobuyoshi Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuyoshi Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuyoshi Shimizu more than expected).
Fields of papers citing papers by Nobuyoshi Shimizu
This network shows the impact of papers produced by Nobuyoshi Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuyoshi Shimizu. The network helps show where Nobuyoshi Shimizu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nobuyoshi Shimizu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 0 | |
| 2 | 2012 | 1 | |
| 3 | 2010 | 1 | |
| 4 | 2008 | 1 | |
| 5 | 2007 | 6 | |
| 6 | 2007 | 7 | |
| 7 | 2006 | 22 | |
| 8 | The relationship between epidermal growth factor receptor(EGFR) mutations and clinico-pathological features in non-small cell lung cancers | 2005 | 2 |
| 9 | 2004 | 6 | |
| 10 | 2003 | 17 | |
| 11 | 2002 | 4 | |
| 12 | LTRPC2 Ca2+-Permeable Channel Activated by Changes in Redox Status Confers Susceptibility to Cell Deathbreakdown → | 2002 | 695 |
| 13 | 2001 | 2 | |
| 14 | HUMAN GENOME PROJECT : CURRENT STATUS, KEIO STRATEGY AND PROSPECTS | 1997 | 1 |
| 15 | 1995 | 1 | |
| 16 | 1992 | 1 | |
| 17 | 1989 | 3 | |
| 18 | 1989 | 3 | |
| 19 | Reconstruction of Air Way | 1988 | 1 |
| 20 | 1987 | 1 |
About Nobuyoshi Shimizu
Nobuyoshi Shimizu is a scholar working on Molecular Biology, Oncology and Genetics, having authored 541 papers that have together received 27.6k indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (41 papers), Transplantation: Methods and Outcomes (38 papers), RNA modifications and cancer (29 papers), Glycosylation and Glycoproteins Research (28 papers), Monoclonal and Polyclonal Antibodies Research (28 papers), HER2/EGFR in Cancer Research (27 papers), Lung Cancer Treatments and Mutations (26 papers) and Chromosomal and Genetic Variations (25 papers). The work is most often cited by research in Physiology (1.6k citations), Neurology (4.7k citations) and Cellular and Molecular Neuroscience (3.5k citations). Nobuyoshi Shimizu has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Shuichi Asakawa, Satoshi Minoshima, Yoshikuni Mizuno, Nobutaka Hattori, Tohru Kitada, Hiroto Matsumine, Yasuhiro Yamamura, Jun Kudoh, Masayuki Yokochi and Motoi Aoe. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.